<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">31287632</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK543393</ArticleId></ArticleIdList><Book><Publisher><PublisherName>Canadian Agency for Drugs and Technologies in Health</PublisherName><PublisherLocation>Ottawa (ON)</PublisherLocation></Publisher><BookTitle book="srrec0577">CADTH Canadian Drug Expert Committee Recommendation: Efinaconazole (Jublia â€” Bausch Health, Canada Inc.): Indication: For the topical treatment of mild to moderate onychomycosis (tinea unguium) of toenails without lunula involvement due to <i>Trichophyton rubrum</i> and <i>Trichophyton mentagrophytes</i> in immunocompetent adult patients</BookTitle><PubDate><Year>2019</Year><Month>05</Month></PubDate><CollectionTitle book="cadthcdrcollect">CADTH Common Drug Reviews</CollectionTitle><Medium>Internet</Medium></Book><Language>eng</Language><PublicationType UI="D016454">Review</PublicationType></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31287632</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
